Clofazimine pharmaceutical API powder — CAS 2030-63-9 — WHO-GMP manufacturer Longshine Boi-Tech, Pune, India
Human APIs

Clofazimine

CAS Registry Number: 2030-63-9

Clofazimine — active pharmaceutical ingredient (API) manufactured to pharmacopoeial specification. Purity ≥99.0%. CAS Registry Number: 2030-63-9. Supplied in bulk quantities from $2800.00/g entry for laboratory research, analytical method d

Product information

Clofazimine — active pharmaceutical ingredient (API) manufactured to pharmacopoeial specification. Purity ≥99.0%. CAS Registry Number: 2030-63-9. Supplied in bulk quantities from $2800.00/g entry for laboratory research, analytical method development, and reference-standard applications.

Product specifications

CAS Registry Number
2030-63-9
Therapeutic Category
Human APIs
API Technology
Synthetic / Semi-synthetic (per molecule)
Development Status
Commercial — stocked
Manufacturer
Longshine Boi-Tech Pvt. Ltd.
Facility
Pune, Maharashtra, India 411001

Regulatory filings & documentation

We maintain regulatory dossiers in the following jurisdictions for Clofazimine-relevant molecules. Letter of Authorization (LoA) and CEP / DMF / ASMF references are issued at no charge to qualified buyers.

US FDA DMF (Type II)
EDQM CEP (where applicable)
Brazil ANVISA
Canada Health Canada
Japan PMDA
Korea MFDS
GCC SFDA
EU CEP
WHO-GMP & ISO 9001:2015 certified. US FDA Drug Master File available. EDQM CEP supplied for EU procurement. Pharmacopoeial release against USP, Ph. Eur., IP, JP. CoA on every batch. First-shipment lead time 7-10 business days for stocked APIs.
View interactive page & request quote Email sales Order a sample

Frequently asked questions about Clofazimine

What is Clofazimine used for?

Clofazimine is supplied as a pharmaceutical-grade human apis for use by regulated pharmaceutical manufacturers, contract development and manufacturing organisations (CDMOs), and research institutions. Buyers using Clofazimine typically reference it under CAS Registry Number 2030-63-9.

What quality and regulatory standards does Longshine Boi-Tech's Clofazimine meet?

Our Clofazimine is manufactured under WHO-GMP and ISO 9001:2015 conditions in Pune, India. Per-batch Certificate of Analysis (CoA) is released against USP / Ph. Eur. / IP / JP specifications depending on destination market. We hold US FDA Drug Master File and EDQM Certificate of Suitability dossiers for the molecules where regulatory recognition is required; Letter of Authorization (LoA) is issued at no charge to qualified buyers.

How do I request a quote, sample, or proforma invoice for Clofazimine?

Quote requests for Clofazimine are turned around within 24 business hours (IST, Pune). Bulk APIs typically ship within 7-10 business days of confirmed PO; air freight to North America and Europe runs 4-5 days door-to-door. Sample agreements are signed before shipping QC-grade material to your formulation laboratory.

Which countries does Longshine Boi-Tech supply Clofazimine to?

We export Clofazimine to 50+ countries including the United States, Canada, Mexico, Brazil, the European Union, the United Kingdom, Japan, Australia, South Korea, the GCC and across South-East Asia. All regulatory documents (DMF / CEP / LoA) and shipping incoterms (EXW, FCA, CIP, DAP, DDP) are negotiated per buyer.

Related Human APIs APIs

Other human apis molecules from Longshine Boi-Tech's WHO-GMP catalogue — each with active regulatory filings, audit-ready CoA, and samples available under CDA.

Heparin Sodium
CAS 9041-08-1
Streptomycin Sulfate
CAS 3810-74-0
Sodium Phenylbutyrate
CAS 1716-12-7
Decitabine
CAS 2353-33-5
Capreomycin Sulfate
CAS 1405-37-4
Erythromycin Estolate
CAS 1264-62-6
Methadone Hydrochloride
CAS 1095-90-5
Cyclophosphamide
CAS 6055-19-2

Related categories & resources

Browse the full Human APIs catalogue or all 560+ products. Reference documents: certifications portfolio · quality system · FDA DMF buyer guide · EU CEP supplier guide · complete product index.